EXECUTIVE ENGAGEMENTS
OUTREACH
948
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
192
Interactions with Platform & by Email
PARTICIPANTS
38
Unique # Participated
VALIDATIONS
11
Responses Validated*
COMPETITORS
42
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
156
PAGES
228
EDITION
9
PRICE
USD $4950
*Engagement stats are ongoing and dynamic
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Specimen Validity Testing estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at aCAGR of 4.9% over the period 2020-2027. Products, one of the segments analyzed in the report, is projected to record 4.8% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 5.1% CAGR for the next 7-year period.
The Specimen Validity Testing market in the U.S. is estimated at US$334.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$279.8 Million by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.
SELECT PLAYERS
Acm Global Laboratories; Alfa Scientific Designs, Inc.; Clinical Reference Laboratory, Inc.; Express Diagnostics Int'l, Inc.; Premier Brands of America, Inc.; Quest Diagnostics, Inc.; Sciteck, Inc.; Thermo Fisher Scientific, Inc.
SEGMENTS
» End-Use (Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers, Other End-Uses) » Product & Service (Products, Services) » Type (Laboratory Testing, Rapid/POC Testing)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Specimen Validity Testing Market: Overview & Outlook |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Increased Prevalence of Substance Abuse: Major Growth Driver |
| Governmental Efforts to Alleviate Drug Abuse Builds Robust Business Case |
| Increased Emphasis on Workplace Drug Testing Augurs Well |
| Saliva Drug Testing: More Suitable for Workplace Testing |
| Emphasis on Creating A Drug-Free Workplace |
| Marijuana Testing Gathers Pace |
| Relevance of Drug Testing for Medical Professionals Drives Demand |
| Increased Opportunities in Alcohol Testing Vertical |
| Growing Use Case in Rehabilitation Centers |
| Regulations |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Specimen Validity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Specimen Validity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Specimen Validity Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Laboratory Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Rapid/POC Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Rapid/POC Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Rapid/POC Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Workplaces by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Workplaces by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Workplaces by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Drug Screening Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Drug Screening Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Drug Screening Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Criminal Justice & Law Enforcement Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Criminal Justice & Law Enforcement Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Criminal Justice & Law Enforcement Agencies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Pain Management Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Pain Management Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Pain Management Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Drug Rehabilitation Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Drug Rehabilitation Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Drug Rehabilitation Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Specimen Validity Testing by Product & Service - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Specimen Validity Testing by Product & Service - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Specimen Validity Testing by Product & Service - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid/POC Testing for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Specimen Validity Testing by Product & Service - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Specimen Validity Testing by Product & Service - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Specimen Validity Testing by Product & Service - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid/POC Testing for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Specimen Validity Testing by Product & Service - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Specimen Validity Testing by Product & Service - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Specimen Validity Testing by Product & Service - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid/POC Testing for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Specimen Validity Testing by Product & Service - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Specimen Validity Testing by Product & Service - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Specimen Validity Testing by Product & Service - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid/POC Testing for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Specimen Validity Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Specimen Validity Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Specimen Validity Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Specimen Validity Testing by Product & Service - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Specimen Validity Testing by Product & Service - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Specimen Validity Testing by Product & Service - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid/POC Testing for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Specimen Validity Testing by Product & Service - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Specimen Validity Testing by Product & Service - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Specimen Validity Testing by Product & Service - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid/POC Testing for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Specimen Validity Testing by Product & Service - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Specimen Validity Testing by Product & Service - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Specimen Validity Testing by Product & Service - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid/POC Testing for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Specimen Validity Testing by Product & Service - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Specimen Validity Testing by Product & Service - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Specimen Validity Testing by Product & Service - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid/POC Testing for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Specimen Validity Testing by Product & Service - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Specimen Validity Testing by Product & Service - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Specimen Validity Testing by Product & Service - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid/POC Testing for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Specimen Validity Testing by Product & Service - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Specimen Validity Testing by Product & Service - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Specimen Validity Testing by Product & Service - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid/POC Testing for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Specimen Validity Testing by Product & Service - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Specimen Validity Testing by Product & Service - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Specimen Validity Testing by Product & Service - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid/POC Testing for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Specimen Validity Testing by Product & Service - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Specimen Validity Testing by Product & Service - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Specimen Validity Testing by Product & Service - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid/POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid/POC Testing for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Screening Laboratories, Criminal Justice & Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Other End-Uses for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 42 |
China Has Risen Into An Economic Powerhouse.
Find Out How You Can Leverage This Opportunity!
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com